Xiang J - Search Results

1

HER2 Splice Site Mutation c.1899-1G>A as the Potential Acquired Resistance to Trastuzumab in a Patient with HER2-Positive Gastric Adenocarcinoma.

Jiao XD, Liu K, Wu Y, Zhou XC, Qin BD, Ling Y, Liu J, He X, Du H, Xiang J, Zang YS. Jiao XD, et al. Among authors: xiang j. Oncologist. 2021 Sep;26(9):717-721. doi: 10.1002/onco.13799. Epub 2021 May 20. Oncologist. 2021. PMID: 33896090 Free PMC article.

2

The landscape of kinase domain duplication in Chinese lung cancer patients.

Wu D, Xie Y, Jin C, Qiu J, Hou T, Du H, Chen S, Xiang J, Shi X, Liu J. Wu D, et al. Among authors: xiang j. Ann Transl Med. 2020 Dec;8(24):1642. doi: 10.21037/atm-20-7408. Ann Transl Med. 2020. PMID: 33490154 Free PMC article.

3

Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).

Peng W, Cao L, Chen L, Lin G, Zhu B, Hu X, Lin Y, Zhang S, Jiang M, Wang J, Li J, Li C, Shao L, Du H, Hou T, Chen Z, Xiang J, Pu X, Li J, Xu F, Loong H, Wu L. Peng W, et al. Among authors: xiang j. Oncologist. 2022 Mar 4;27(2):e116-e125. doi: 10.1093/oncolo/oyab044. Oncologist. 2022. PMID: 35641209 Free PMC article.

4

Clinical Characteristics and Molecular Patterns of RET-Rearranged Lung Cancer in Chinese Patients.

Zhang K, Chen H, Wang Y, Yang L, Zhou C, Yin W, Wang G, Mao X, Xiang J, Li B, Zhang T, Fei S. Zhang K, et al. Among authors: xiang j. Oncol Res. 2019 May 7;27(5):575-582. doi: 10.3727/096504018X15344979253618. Epub 2018 Aug 21. Oncol Res. 2019. PMID: 30131091 Free PMC article.

5

Durable Clinical Response of Lung Adenocarcinoma Harboring EGFR 19Del/T790M/in trans-C797S to Combination Therapy of First- and Third-Generation EGFR Tyrosine Kinase Inhibitors.

Zhou Z, Zhao Y, Shen S, Gu L, Niu X, Xu Y, Zhang T, Xiang J, Mao X, Lu S. Zhou Z, et al. Among authors: xiang j. J Thorac Oncol. 2019 Aug;14(8):e157-e159. doi: 10.1016/j.jtho.2019.04.020. Epub 2019 May 7. J Thorac Oncol. 2019. PMID: 31075545 Free article. No abstract available.

6

Frequency, clinical features and differential response to therapy of concurrent ALK/EGFR alterations in Chinese lung cancer patients.

Liu J, Mu Z, Liu L, Li K, Jiang R, Chen P, Zhou Q, Jin M, Ma Y, Xie Y, Xiang J, Li B, Ma Y, Mao X, Zhang L, Zhang T, Wu D. Liu J, et al. Among authors: xiang j. Drug Des Devel Ther. 2019 May 23;13:1809-1817. doi: 10.2147/DDDT.S196189. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31213769 Free PMC article.

7

Characterization of acquired receptor tyrosine-kinase fusions as mechanisms of resistance to EGFR tyrosine-kinase inhibitors.

Xu H, Shen J, Xiang J, Li H, Li B, Zhang T, Zhang L, Mao X, Jian H, Shu Y. Xu H, et al. Among authors: xiang j. Cancer Manag Res. 2019 Jul 9;11:6343-6351. doi: 10.2147/CMAR.S197337. eCollection 2019. Cancer Manag Res. 2019. PMID: 31372039 Free PMC article.

8

A first case report of clinical response to targeted therapy in a patient with primary myoepithelial carcinoma of the lung harboring EGFR exon 19 deletion.

Xie X, Lin X, Liu M, Qin Y, Ouyang M, Li S, Gu Y, Chen S, Xiang J, Zhou C. Xie X, et al. Among authors: xiang j. Diagn Pathol. 2020 Jun 6;15(1):71. doi: 10.1186/s13000-020-00986-0. Diagn Pathol. 2020. PMID: 32505185 Free PMC article.

9

Characterization of MET exon 14 alteration and association with clinical outcomes of crizotinib in Chinese lung cancers.

Yang H, Zhou Z, Lin L, Yang M, Li C, Li Z, Yu X, Lizaso A, Han-Zhang H, Li B, Xiang J, Mao X, Xu Q, Zhang Y, Yang N. Yang H, et al. Among authors: xiang j. Lung Cancer. 2020 Oct;148:113-121. doi: 10.1016/j.lungcan.2020.08.009. Epub 2020 Aug 19. Lung Cancer. 2020. PMID: 32889305

10

Integrated histological and molecular analyses of rebiopsy samples at osimertinib progression improve post-progression survivals: A single-center retrospective study.

Cheng JT, Yao YH, Gao YE, Zhang SL, Chen HJ, Wang Z, Yan HH, Zhou Q, Tu HY, Zhang XC, Su J, Xie Z, Lizaso A, Chen SY, Lin X, Xiang JX, Wu YL, Yang JJ. Cheng JT, et al. Among authors: xiang jx. Lung Cancer. 2020 Dec;150:97-106. doi: 10.1016/j.lungcan.2020.10.010. Epub 2020 Oct 20. Lung Cancer. 2020. PMID: 33126092

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,281 results

Search Page

Filters